Centessa Pharmaceuticals (CNTA)

NASDAQ: CNTA · Real-Time Price · USD

13.54

-0.17 (-1.24%)

At close: May 01, 2025, 3:59 PM

13.50

-0.33%

Pre-market: May 02, 2025, 04:41 AM EDT

Centessa Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-235.76M	-151.09M	-216.21M	-381.85M	-10.66M	-5.06M
Depreciation & Amortization	942K	810K	131K	33.99K	n/a	6K
Stock-Based Compensation	33.55M	29.39M	24.96M	14.85M	336K	236K
Other Working Capital	26.69M	-16.13M	-9.18M	1.34M	-440K	-1.86M
Other Non-Cash Items	34.46M	6.03M	-3.75M	257.85M	186K	-770
Deferred Income Tax	2.65M	-26.63M	-2.86M	-6.8M	n/a	770.00
Change in Working Capital	22.1M	-18.86M	-2.83M	-5.38M	-489K	-1.01M
Operating Cash Flow	-142.06M	-160.34M	-200.55M	-136.14M	-10.63M	-5.83M
Capital Expenditures	-34K	-169K	-1.14M	-185.98K	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	63.43M	n/a	n/a
Purchase of Investments	-140.53M	-264.91M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	138.07M	n/a	n/a	n/a	n/a
Other Investing Acitivies	171.83M	n/a	206K	-1	n/a	n/a
Investing Cash Flow	31.27M	-127M	-931K	63.25M	n/a	n/a
Debt Repayment	-762K	n/a	n/a	73.93M	1.36M	3.83M
Common Stock Repurchased	n/a	n/a	n/a	-12K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	5.91M	310K	457K	586.14M	1K	6K
Financial Cash Flow	364.75M	21.12M	457K	660.07M	1.36M	9.01M
Net Cash Flow	255.19M	-265.61M	-201.44M	590.08M	-9.34M	3.7M
Free Cash Flow	-142.09M	-160.51M	-201.68M	-136.33M	-10.63M	-5.83M